Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

Figure 3

Patients' relative frequencies of clinical and/or ultrasonographic outcomes according to treatment group. DAS28R, clinical remission according to the disease activity score among 28 joints; LDA, low disease activity; MTX, methotrexate monotherapy; MTX+PDN, methotrexate + prednisone combination therapy; PDneg, power Doppler signal negativity; DAS28R+PDneg, combined outcome of clinical remission according to disease activity score among 28 joints and power Doppler negativity. *P < 0.05 related to differences between treatment arms.

Back to article page